SPOTLIGHT: Bisaro handed reigns at Watson


Paul M. Bisaro, currently the president and COO of Barr Pharmaceuticals, has been tapped to take the CEO post at Watson Pharmaceuticals. Current CEO Allen Chao, Ph.D. is retiring. Release

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.